首页> 外文OA文献 >Risk factors of post renal transplant anaemia among Sudanese patients, a study in three renal transplant centres.
【2h】

Risk factors of post renal transplant anaemia among Sudanese patients, a study in three renal transplant centres.

机译:在三个肾移植中心进行的一项研究中,苏丹患者中肾移植后贫血的危险因素。

摘要

BACKGROUND: There is a relative lack of recent information about late post kidney transplantation anaemia (PTA), especially in the developing countries; data are scarce about the prevalence and risk factors of PTA. Sudan was a leading country in Africa and Arab world in kidney transplantation. The first kidney transplantation in Sudan was in 1973.METHODS: This is a cross-sectional hospital analytic study enrolling all kidney transplanted recipients following in the transplant referral clinics at Ahmed Gassim, Selma and Ibn Sina Hospitals, Khartoum/Sudan, in the period from 1/8/2010 to 1/9/2010, clinical and laboratory data were obtained from 114 patients, anaemia was defined as Hb levels of u3c 13 g/dl for male patients and u3c 12 g/dl for female patients, exclusion criteria were pregnancy, below 18 years old patients, multiple organ transplantation, and patients with less than one year from the transplantation.RESULTS: The study showed that 39.5% of the patients were anaemic. Univariate analysis showed that late PTA is significantly associated with not using Erythropoietin (EPO) in the pre-transplant period (p = u3c 0.001), history of rejection (p = 0.003), longer time from transplantation (p = 0.015), and eGFR (p u3c 0.0001). Multivariate analysis showed that eGFR (p = u3c 0.001) and not use of EPO in the pre transplant period (p u3c 0.001) are strong predictors of PTA. The use of Angiotensin converting enzyme inhibitors/Angiotensin receptors blockers (ACEI/ARB), immunosuppressive treatments, presence or absence of co-morbidities, donor type and donor age are not significantly associated with late PTA.CONCLUSION: The study concluded that late PTA is common and under recognized. Risk factors for late PTA include renal dysfunction, history of rejection, longer duration of transplantation and not using EPO in the pre-transplant period. Renal dysfunction and not using EPO in the pre-transplant period are major predictors of late PTA.
机译:背景:特别是在发展中国家,相对缺乏关于晚期肾移植后贫血(PTA)的最新信息。有关PTA的患病率和危险因素的数据很少。苏丹是非洲和阿拉伯世界肾脏移植的领先国家。苏丹于1973年进行了首次肾脏移植。方法:这是一项横断面医院分析研究,招募了所有肾脏移植受者,随后在喀土穆/苏丹的塞尔玛市艾哈迈德·加西姆和苏丹伊本·西那医院的移植转诊诊所进行了研究。从2010年1月8日至2010年1月9日,从114例患者中获得临床和实验室数据,贫血定义为男性患者的Hb水平为 u3c 13 g / dl,女性为 u3c 12 g / dl标准是怀孕,18岁以下的患者,多器官移植以及移植后不到一年的患者。结果:研究表明,有39.5%的患者患有贫血。单因素分析显示,PTA晚期与移植前未使用促红细胞生成素(EPO)显着相关(p = u3c 0.001),排斥反应的历史(p = 0.003),移植时间更长(p = 0.015)和eGFR(p u3c 0.0001)。多变量分析显示,eGFR(p = u3c 0.001)和移植前未使用EPO(p u3c 0.001)是PTA的强力预测指标。结论:研究认为,PTA晚期与PTA晚期无关。使用血管紧张素转换酶抑制剂/血管紧张素受体阻滞剂(ACEI / ARB),免疫抑制治疗,是否存在合并症,供体类型和供体年龄均无显着相关性。常见且未得到认可。晚期PTA的危险因素包括肾功能不全,排斥反应史,移植时间较长以及在移植前不使用EPO。肾功能不全和移植前未使用EPO是PTA晚期的主要预测指标。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号